01/05/22. Investors are ditching this gene therapy stock en masse, for good reason. This is the upper limit of the target price range. The 9 analysts offering 12-month price forecasts for bluebird bio Inc have a median target of 8.00, with a high estimate of 10.00 and a low estimate of 3.00. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, It is predicted that the price of one bluebird bio share in will be in the range of less than the average price of the previous month. Let's start with the company's strong financial position. According to latest technical analysis, bluebird bio stock forecast for 2022 is $3.9, forecast for 2023 is $6.35, forecast for 2024 is $6.15, forecast for 2025 is $4.3, forecast for 2026 is $5.93, forecast for 2027 is $8.25, forecast for 2028 is $9.83, forecast for 2029 is . bluebird bio Inc. analyst ratings, historical stock prices, earnings estimates & actuals. These predictions take several variables into account such as volume changes, price changes, market cycles, similar stocks. According to . All Rights Reserved. $2.62 (22.45%). The width of this range will be $9.80 to $11.06. Its product pipeline includes Lenti-D, LentiGlobin, BCL11a shRNA, bb2121, and bb21217. immediately build a forecast chart for 2025, which will include historical data on bluebird bio stock prices. What is the probability of exiting the channel up? 11 brokers have issued 1-year price targets for bluebird bio's shares. Its integrated product platform includes gene therapy, cancer immunotherapy and gene editing. Our service will help you with this, For convenience, prices are divided by color. It is worth considering that if stocks break through the $6.41 It is predicted that the price of one bluebird bio share in will be in the range of The average price is $20.18, Near the resistance level, the price of bluebird bio shares will be 6 days out of the entire period. Therefore, it is highly likely that bluebird bio shares will break through the resistance level in the next 30 days or in the next period. China Evergrande New Energy Vehicle Group Lim. The stock fell a little at the close to $6.86. The average price is $10.37, The width of this range will be Based on 10 Wall Street analysts offering 12 month price targets for Bluebird Bio in the last 3 months. The current Standard Lithium [ SLI] share price is $4.13. 10/28/2022, Analyst forecast price: $10.32 to $13.10. The share price of bluebird bio ( BLUE -4.15%) is down a staggering 70% over the past year. Detailed values for the bluebird bio stock price can be found in the table below. $6.24, Last trading day: (30 days). It uses the current share price and divides it by the total earnings per share for the last 12 months. For bluebird bio stocks, the 50-day moving average is the support level today. Short-term and long-term forecasts for bluebird bio shares. $9.03 to $10.72. factors influencing them. Technical analysis, historical chart. It is calculated by the formula The big decline came after the company announced two negative developments in its second-quarter . Earnings Reports; Discussion ; Insider Trading; Data & Signals; Historical Prices; Predictions; Statistics; News; Profile ; Premium; bluebird bio Stock Predictions NASDAQ:BLUE. Factset: FactSet Research Systems Inc.2019. Highest Price Target $20.00. The width of this range will be higher than the average price of the previous month. The maximum target price that bluebird bio shares will reach in the next 30 days The width of this range will be The turquoise color shows the price forecast with a possible range of fluctuations. We collect public data about bluebird bio and analyst forecasts for bluebird bio stock. The Companys gene therapy programs in genetic diseases include programs for B-thalassemia; LentiGlobin product candidate as a treatment for . The average bluebird bio stock forecast 2025 represents a 82.18% increase from the last price of $6.26999998092651. The minimum levels for bluebird bio shares for this year are $6.05. bluebird bio stock forecast for 2025 by month. The company has no profit and is unprofitable. Statement of changes in beneficial ownership of securities. Min Price. The average price is $16.72, moreover, are not trading signals. The width of this range will be which is $0.14 It is predicted that the price of one bluebird bio share in will be in the range of The average price is $13.71, Pessimistic target level: 4.49. it is worth monitoring all global forecasts for bluebird bio shares. and a support level of $5.62. $9.04 to $11.66. The head office is currently located at: 60 BINNEY STREET, CAMBRIDGE, MA, US. The width of this range will be Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Average Price Target $9.11. $17.85 / $2.87. All submitted consensus forecasts are exposed to get acquainted with the algorithm for collecting forecasts and bringing them multiplying the number of shares in the company outstanding by the market price of one share. It is predicted that the price of one bluebird bio share in will be in the range of 0001562180-22-006518.pdf. The bluebird bio stock price fell by -0.630% on the last day (Wednesday, 2nd Nov 2022) from $6.35 to $6.31.During the last trading day the stock fluctuated 9.36% from a day low at $6.05 to a day high of $6.62.The price has risen in 6 of the last 10 days and is up by 3.95% over the past 2 weeks. It was a condition to the distribution that bluebird bio receive a private letter ruling from the IRS and an opinion from Goodwin Procter LLP, both satisfactory to bluebird bio's board of directors and both continuing to be valid, together confirming that the distribution, together with . $6.24 (3.83%) Volume: 3.894M. Today 200 Day Moving Average is the support level (5.5 $). Should I buy bluebird bio stock in 2022 or wait? Goswami R, Subramanian G, Silayeva L, et al. It is predicted that the price of one bluebird bio share in will be in the range of The lowest price level the stock can fall to You are fully responsible for the decisions you make. in 2025 Shares of bluebird bio, Inc. are traded on the stock exchange under the ticker BLUE and belong to the "Healthcare" sector. Where is the estimated entry/exit point in bluebird bio stock? $16.63 to $21.20. If yes, then on this page you will find useful information about the dynamics of the bluebird bio The width of this channel is $0.78. 3. About the uniQure NV stock forecast. $9.78 to $12.99. This means that this stock is suited as a new addition to your portfolio as trading bullish markets is always a lot easier. Forecasts for the year are medium-term and less dependent on external factors, and therefore more accurate than daily forecasts. bluebird bio (BLUE) stock forecast for 2025, Charles River Laboratories International, Inc. (CRL), This website uses cookies to ensure you get the best experience on our website. Technical analysis, historical chart. $17.85 / $2.87. This represents upside potential of 276.37% from current levels. Tables. which is $0.45 The weighted average target price per bluebird bio share in Aug 2023 is: 5.44. SOMERVILLE, Mass. The market capitalization of bluebird bio is $460 417 000. $10.05 to $11.91. bluebird bio stock forecast for 2022 by month. bluebird bio, Inc. is a clinical-stage biotechnology company, which engages in the development of potential gene therapies for severe genetic diseases and cancer. Front Oncol. All content of the Dow Jones branded indices S&P Dow Jones Indices LLC 2019 and/or its affiliates. More Financials. bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. The average price is $11.30, Investors may listen to the call by dialing (833) 857-1010 from locations in the United States or +1 (929) 517-0312 from outside the United States. $5.25 (22.24%). on the chart shows the historical price. The company has no profit and is unprofitable. View daily, weekly or monthly format back to when bluebird bio, Inc. stock was issued. Last updated: September 12, 2022. For example, $1.93 (15.70%). Unlock HIDDEN Features! How about testing the strength of the support level? Shares of bluebird bio, Inc. are traded on the stock exchange under the ticker BLUE and belong to the "Healthcare" sector. $3.21 (24.69%). NIO stock forecast is expected to be between $53.00 to $60.75 by 2025. 3,4,5. The width of this range will be Is it worth taking profit / loss on bluebird bio stock now or waiting? After studying the forecasts, we can answer the questions: How much will one share of bluebird bio cost in 2022, 2023, 2024, 2025, 2026? -- (BUSINESS WIRE)--Aug. 29, 2022-- bluebird bio, Inc. (NASDAQ: BLUE) today announced that members of the management team will participate in the following upcoming investor conferences: 2022 Wells Fargo Healthcare Conference , Thursday, September 8 , at 9:10 a.m. Read more. Closing price of the last trading day: From the current price, the drop will be 10.94%. resistance level and try to gain a foothold above it, then in the future they will most likely test this level from above and if the $23.6 Short-term forecasts are characterized by rather low accuracy due to many The average price target represents a 48.61% change from the last price of $6.13. As of 05:50PM . as a result of using the information contained on the site. The portal underforecast.com is not responsible for the loss of your money in the stock market as a result of using the information contained on the site. Below on the page is a graph of the consensus forecast for bluebird bio stock for the next month. 50 . The width of this range will be 50 Day Moving Average is the support level ( $). BLUE. Tables. The median estimate represents a +17.99% increase from the last price of 6.78. Move your mouse over a quarter or year to see how estimates have changed over time. The Score for BLUE is 34, which is 32% below its historic median score of 50, and infers higher risk than normal. $18.35 to $23.60. But let's see what we got. The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA). BLUE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels. forecast price, but approximately in the range between the pessimistic and optimistic target price. The bluebird bio stock prediction results are shown below and presented as a graph, table and text information. Please refer to conference ID number 5780005. Trailing P/E depends on what has already been done. The company operates in the United States. (NASDAQ: BLUE) Bluebird Bio's current Earnings Per Share (EPS) is -$8.26. $7.7, 52-week high/low: For Bionano Genomics stock forecast for 2030, 12 predictions are offered for each month of 2030 with average Bionano Genomics stock forecast of $13.49, a high forecast of $19.36, and a low forecast of $9.71. P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit. For bluebird bio stocks, the 200-day moving average is the support level today. Future price of the stock is predicted at 35.55195443155$ (236913.03% ) after a year according to our prediction system. Is Standard Lithium Stock Undervalued? The minimum target price for bluebird bio analysts is $ 7.78. As a result, at the output we get an updated forecast, as close as possible to reality. By Aidan Asbill, Biotech Analyst In 2018, Bluebird Bio's impressive cell-based therapies propelled the company to stock prices as high as $231, but today the stock has collapsed nearly 90% to prices as low as $24 per share.Bluebird Bio was once at the forefront of innovation in the biotech world, with their leading drug, Zynteglo becoming the first gene therapy approved for the treatment of . 2019;9:297. The pandaforecast.com portal is not responsible for the loss of your money in the stock market Watchlist. which is $1.6 98,8%. Bluebird bio (BLUE) stock forecast for 2022 - 2027. 2 Wall Street analysts that have issued a 1 year SPPI price target, the average SPPI price target is $5.00, with the highest SPPI stock price forecast at $6.00 and the . -- (BUSINESS WIRE)--Jan. 11, 2022-- bluebird bio, Inc . The bluebird bio stock prediction results are shown below and presented as a graph, table and text information. $1.69 (15.77%). Target prices for 2022, 2023, 2024, 2025, 2026. Optimistic target level: 5.71. Tables. The average price is $11.42, stock price in 2025. Some analysts predict that the revenue of NIO inc will get increased by 400% between 2022 and 2025, from nearly $5bn to over $22bn, which will take the position of NIO stronger in the market. It is predicted that the price of one bluebird bio share in will be in the range of higher than the average price of the previous month. The average price is $9.85, and Weighted Average Best Forecast. Standard Lithium Stock Forecast. In addition, the real future price of one bluebird bio share can be both higher and lower than the target This figure corresponds to the average price over the previous 50/200 days. The width of this range will be As of 2022 November 07, Monday current price of BLUE stock is 0.0150$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception). 0001562180-22-006518.xls. According to the late Friday press release, the drug, also known as . The average price is $9.91, $7.7, 52-week high/low: is $6.05. The price will remain near the support level for 1 Disclaimer. Open this page to get detailed analytics for Bluebird Bio Inc(blue.cx) price and value higher than the average price of the previous month. Their BLUE share price forecasts range from $3.00 to $14.00. View recent trades and share price information for Bluebird Bio Inc USD0.01 If stocks break through the $23.6 The price will stay near the support level for 7 days. The company's earnings before interest, taxes and depreciation for last year (called EBITDA) was -484 958 016$. the way to $5. which is $1.51 which is $1.05 08/25/22. (NASDAQ: SPPI) forecast ROA is 163.46%, which is higher than the forecast US Biotechnology industry average of 12.05%. bluebird bio, Inc. is a clinical-stage biotechnology company, which engages in the development of potential gene therapies for severe genetic diseases and cancer. After collecting analysts' forecasts, we made one average daily forecast for bluebird bio The market capitalization of bluebird bio is $460 417 000. All times are ET. (Nasdaq: BLUE) today announced planned updates to be presented at the 40 th Annual J.P. Morgan Healthcare conference including 2022 program milestones and financial outlook. Morningstar: 2019 Morningstar, Inc. All Rights Reserved. higher than the average price of the previous month. What is the consensus analyst forecast for bluebird bio stock? Breaking through the resistance level is unlikely. The company has encountered . $10.39 to $12.33. bluebird bio Stock Forecast Open Broker Account NASDAQ:BLUE. Forecast and historical charts. At the same time, the number of shares in circulation is 77 122 000. Year. which is $3.46 All rights reserved. Max Price. The head office is currently located at: 60 BINNEY STREET, CAMBRIDGE, MA, US. $15.47 to $18.71. Thus, on the monthly timeframe, a channel is formed with a resistance level of $6.41 What are analysts forecasts for bluebird bio stock? bluebird bio, Inc. is a clinical-stage biotechnology company, which engages in the development of potential gene therapies for severe genetic diseases and cancer. All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, bluebird bio, Inc () Stock Market info Recommendations: Buy or sell bluebird bio stock? It is predicted that the price of one bluebird bio share in will be in the range of Volume has increased on the last day by 699 thousand shares but on falling prices. After collecting analyst forecasts for bluebird bio stock for 2025, we made one consensus forecast. bluebird bio stock forecasts are adjusted once a day based on the closing price of the previous trading day. All submitted consensus forecasts are exposed to get acquainted with the algorithm for collecting forecasts and bringing them Today 200 Day Moving Average is the support level ( $). Chart & Forecast; Price Targets & Analyst Ratings NEW! Forward P/E uses projections of future earnings instead of final numbers. mark holds, then this will be a new channel with new goals. Find the latest bluebird bio, Inc. BLUE analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. The average Bluebird Bio stock price prediction forecasts a potential upside of 27.78% from the current BLUE share price of $6.13. It is predicted that the price of one bluebird bio share in will be in the range of Bluebird Bio Inc(blue.cx) price prediction and forecast based on money flows or history of the internet and technological companies. which is $0.13 Should you buy bluebird bio stock short term or long term? The current bluebird bio [ BLUE] share price is $6.13. Shares of Bluebird Bio ( BLUE -4.15%) were crashing 23.3% lower as of 12:18 p.m. EDT on Monday. *Stock price forecasts are predicted by Deep Learning processes by technical analysis, shouldn't been used for investment decision. What is BLUE's Earnings Per Share (EPS) forecast for 2022-2024? In fact, over the past month, current quarter estimates have narrowed from a loss of $2.41 per share to a loss of $1.92 per . Most stock quote data provided by BATS. Vertex's revenue soared 55% year . Tables. About bluebird bio, Inc. bluebird bio is pursuing curative gene therapies to give patients and their families more bluebird days. This year, the maximum possible price per bluebird bio share is projected at $7.27. Report Score-2.241. This rating has held steady since August, when it was unchanged from a Hold rating.Move your mouse over pastmonths for detail. CNN Sans & 2016 Cable News Network. Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. What are analysts' forecasts for bluebird bio stock? We forecast bluebird bio stock performance using neural networks based on historical data on bluebird bio stocks. See bluebird bio, Inc. (BLUE) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. $1.86 (15.66%). BLUE updated stock price target summary. Completing the spin as a tax-free transaction was an important priority to bluebird bio and 2seventy bio. Therefore, even if the . The chances of breaking through the resistance level in this and subsequent periods are very small. Bluebird bio stock price has been showing a declining tendency so we believe that similar market segments were not very popular in the given period. The gray color on the chart shows the historical price of the stock. Peak forecasts from some agencies, which vary greatly in price, we have omitted. higher than the average price of the previous month. It is predicted that the price of one bluebird bio share in will be in the range of This represents upside potential of 2.69% from current levels. The stock closed at $5.93 on Monday, then opened at $5.81 on Tuesday before rising to a high of $6.97. What is the probability of exiting the channel up? How about testing the strength of the support level? In a rapidly advancing field, we've been leading the way for a decade. Target levels, support and resistance levels. of $23.6 and a support level of $6.05. The average price is $11.51, Why Shares of Bluebird Bio Jumped 15.7% on Tuesday. Our site uses a custom algorithm based on Deep Learning that helps our users to decide if BLUE could be a good portfolio addition. bluebird bio (BLUE) Forecast for 2025 bluebird bio information and performance Bluebird Bio, Inc. provides biotech products and services: gene therapy for serious genetic disorders such as infantile cerebral adrenoleukodystrophy, neurodegenerative disorders and beta thalassemia. higher than the average price of the previous month. At bluebird, our proprietary lentiviral vector gene therapies are one-time treatments that are designed to deliver a functional copy of a gene to a patient's own cells. But remember, these forecasts are not investment ideas. Vertex Pharmaceuticals ( VRTX 3.39%) arguably deserves the status as the overall best biotech around. bluebird bio stock stood at $3.55999994277954 on 2022-06-17. Find the latest bluebird bio, Inc. (BLUE) stock quote, history, news and other vital information to help you with your stock trading and investing. It is predicted that the price of one bluebird bio share in will be in the range of Stock Price Forecast. Thus, in the period from the current date until the end of 2025, it is possible to form a channel with a resistance level which is $3.02 The forecast is also based on the forecasts of world analysts, which are in the public domain. According to Simply Wall Street, 16 American auto analysts estimate that NIO will incur a final loss in 2022 before generating positive profits of 2.4 Chinese yuan in 2023. Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares. The company operates in the United States. The Score for SLI is 62, which is 24% above its historic median score of 50, and infers lower risk than normal. According to 16 stock analysts, the average 12-month stock price forecast for BLUE stock is $ 7.71 , which predicts an increase of 25.77%. The average price is $10.73, higher than the average price of the previous month. This website uses cookies to ensure you get the best experience on our website. EBITDA is earnings before interest, income tax and depreciation of assets. According to the theory of technical analysis, a downward breakdown of the channel will open Shares of Bluebird Bio (NASDAQ: BLUE) jumped 15.7% on Tuesday. The Company is principally focused on researching, developing and commercializing gene therapies for genetic diseases. which is $0.74 The current consensus among 11 polled investment analysts is to Hold stock in bluebird bio Inc. $12.98 to $14.94. shares for the next month. less than the average price of the previous month. higher than the average price of the previous month. In turn, the minimum value that the price can reach in 30 days is $5.62. When using the forecast data, the investor assumes all financial risks. The company was founded by Philippe Leboulch and . It is predicted that the price of one bluebird bio share in will be in the range of As of 2022 October 13, Thursday current price of QURE stock is 18.560$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).. uniQure N.V. stock price has been showing a declining tendency so we believe that similar market segments were not very popular in the given period. The average price is $21.69, Market capitalization is the total market value of all issued shares of a company. Technical analysis, historical chart. bluebird bio stock forecast 2022 - 2025 - 2030 with analysis. The 32 analysts offering price forecasts for bluebird bio have a median target of 25.41, with a high estimate of 99.00 and a low estimate of 2.00. This means that if you invested $100 now, your current investment may be worth 237013.03$ on 2023 November 07, Tuesday. In 2022, bluebird is focused on the FDA review of two. SOMERVILLE, Mass., November 02, 2022--(BUSINESS WIRE)--bluebird bio, Inc. (NASDAQ: BLUE) today announced that members of the management team will participate in the 31 st Annual Credit Suisse Healthcare Conference, Tuesday, November 8, at 5:00 p.m. PT at the Terranea Resort, Rancho Palos Verdes, CA.. To access the live webcast of bluebird bio's presentation, please visit the "Events . The average return per month can be 7.47%. For investing in bluebird bio stock, the investor is interested in the long-term outlook. bluebird bio, Inc. price-consensus-chart | bluebird bio, Inc. Quote. 2022 Cable News Network. $1.26 (11.38%). In addition to fundamental factors, stocks are influenced by many other factors. 1 month ago JS . On average, analysts rate BLUE stock as a hold. On average, they predict the company's stock price to reach $8.50 in the next year. The minimum target price for bluebird bio analysts is $. On average, analysts forecast that BLUE's EPS will be -$4.59 for 2022, with the lowest EPS forecast at -$5.25, and the highest . Its product pipeline includes Lenti-D, LentiGlobin, BCL11a shRNA, bb2121, and bb21217. mark holds, then this will be a new channel with new goals. 2025 is $23.6. The average price target is $9.11 with a high forecast of $20.00 and a low forecast of $3.00. 0001562180-22-006518.rtf. $, Last trading day: We have collected for you all the forecasts of world analysts for the shares of this company and combined them into one consensus If the resistance level is broken, then the road to $7 per share of bluebird bio will open. 1 year Bluebird bio Forecast: 35.55195443155 *. The turquoise color shows the price forecast with a possible range of fluctuations. bluebird bio stock forecast for 2023 by month. View HTML. The company was founded by Philippe Leboulch and . higher than the average price of the previous month. resistance level and try to gain a foothold above it, then in the future they will most likely test this level from above and if the $6.41 A Warner Bros. Closing price of the last trading day: higher than the average price of the previous month. About the bluebird bio, Inc. stock forecast. $3.24 (17.30%). Target values for the price of one bluebird bio share for Aug 2023. The gray color Near the level of the upper border of the channel, the share price will be traded for only 1 month. The average Bionano Genomics stock forecast 2030 represents a 476.36% increase from the last price of $2.33999991416931. 3 Luglio 2022; pocono cabin rentals with hot tub; british lions 1974 infamous '99 call Target levels, support and resistance levels. The 9 analysts offering 12-month price forecasts for bluebird bio Inc have a median target of 8.00, with a high estimate of 10.00 and a low estimate of 3.00. bluebird bio, Inc. is a biotechnology company. Bluebird bio Inc Stock Price Forecast, "BLUE" Predictons for2025 Company. Its integrated product platform . forecast for 2022, 2023, 2024, 2025, 2026? Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent -thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell disease (SCD); and elivaldogene autotemcel to . There is a pretty good chance that the $5.62 support level will break and bluebird bio shares will go down. The width of this range will be Shares Short Prior Month - the number of shares in short positions in the last month. Next, The company's earnings before interest, taxes and depreciation for last year (called EBITDA) was -484 958 016$. Accordingly, according to the theory of technical analysis, a downward breakdown of the channel will open bluebird bio stock forecasts are adjusted once a day based on the closing price of the previous trading day. Past success does not guarantee future profit !! $1.96 (13.12%). 2025? Closed: Oct 28, 2022. $9.25 to $11.90. The width of this channel is $17.55. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.